This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Bio-Techne Corp. shed 5.8% to $46.66 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.6% to 5,844.61 and Dow Jones Industrial Average falling 1.9% to 41,860.44.
The stock's fall snapped a four-day winning streak.
Bio-Techne Corp. closed 44.4% short of its 52-week high of $83.96, which the company achieved on May 23rd.
The stock demonstrated a mixed performance when compared to some of its competitors, as Amgen Inc. fell 1.3% to $271.34, Charles River Laboratories International Inc. fell 6.0% to $134.98, and BioMarin Pharmaceutical Inc. fell 2.42% to $58.48.
Trading volume totaled 2.3 million, compared to the 50-day average of 2.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 21, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。